Analyst Ratings for Neuphoria Therapeutics Inc. (NEUP)
NEUP Rating Summary
NEUP Price Target Summary
- Highest: $35.00 (Maxim Group)
- Lowest: $2.30 (Lucid Capital Markets)
- Average: $18.65
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$18.65 (+445.3%)
* Over Last 12-Mos
Rating Score: 0 / 10
Avg. $ Target:
$18.65 (+445.3%)
* Over Last 12-Mos
Rating Score: 0 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/15/2026 | H.C. Wainwright | Joseph Pantginis | Downgrade | Neutral (Buy) |
N/A (N/A) |
5.09 (3.42) |
-32.81% | Details |
| 10/21/2025 | Lucid Capital Markets | Elemer Piros | Downgrade | Neutral (Buy) |
2.30 (81.00) |
15.40 (3.42) |
-77.79% | Details |
